Synthesis, antihistaminic and cytotoxic activity of pyridothieno- and pyridodithienotriazines

European Journal of Medicinal Chemistry

Volumn 33, Issue 11, 1998, Pages 887-897

  Quintela, José Maria ^a   Peinador, Carlos ^a   Veiga, Mari Carmen ^a   Botana, Luis M ^b   Alfonso, Amparo ^b   Riguera, Ricardo ^c  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b Universidad de Santiago da Compostela   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Antihistaminic; Cytotoxicity; Pyridodithienoditriazines; Pyridothienotriazines

Indexed keywords

TRIAZINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; CYTOTOXICITY; HISTAMINE RELEASE; INHIBITION KINETICS; MAST CELL; NONHUMAN; RAT; STIMULATION; SYNTHESIS;

EID: 0032293347     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(99)80013-0     Document Type: Article

References (29)

1. [1] Thomas L.L., Chem. Immunol. 61 (1995) 186-207.
2. [2] Fleming D.M., Crombie D.L., Br. Med. J. 294 (1987) 279-28.
3. [3] Sano A., Masami I., Yoshihara J., Sumino M., Nawa H., Chem. Pharm. Bull. 43 (1995) 683-685.
4. [4] Cox J., Beach J., Blair M., Clarke A., King J., Lee T., Loveday D., Moss G., Orr T., Ritchie J., Sheard P., Adv. Drugs Res. 5 (1970) 115-196.
5. [5] Assem E., Ritcher A., Immunol. Lond. 21 (1971) 729-730.
6. [6] Foreman J., Garland L., Br. Med. J. 1 (1976) 820-821.
7. [7] Unangst P.C., Brown R.E., Herzig D.J., J. Med. Chem. 23 (1980) 1251-1255.
8. [8] Klaubert D.H., Sellstedt J.H., Ginosso C.J., Bell S.C., Capetola S.J., J. Med. Chem. 24 (1981) 748-752.
9. [9] Phillip A., Jirkousky I., Martel R.R., J. Med. Chem. 23 (1980) 1372-1376.
10. [10] Schwender C.F., Sunday B.R., Kerbleski J.J, Herzig D.J., J. Med. Chem. 23 (1980) 964-972.
11. [11] Madding G.D., Thompson M.D., J. Heterocycl. Chem 24 (1987) 581-586.
12. [12] Sherlock M.H., Kaminski J.J., Tom W.C., Lee J.F., Wong S.C., Kretner W., Bryant R.W., McPhail A.T., J. Med. Chem. 31 (1988) 2108-2121.
13. [13] Kreutner W., Sherwood J., Sehring S., Rizzo C., Chapman R.W., Siegel M.I., Egan R.W., J. Pharmacol. Exp. Ther. 247 (1988) 997-1003.
14. [14] Youssefyeh R.D., Brown R.E., Uresh Shah J.W., Jones H., Loev B., Khandwala A., Liebowitz M.J., Jonnino-Goldman P., J. Med. Chem. 27 (1984) 1639-1643.
15. [15] Khandwala A., Van Inwegen R., Coutts S., Dally-Meade V., Youssefyeh R.D., Int. J. Immunopharmacol. 5 (1983) 491-502.
16. [16] Quintela J.M., Peinador C., Botana L., Estevez M., Riguera R., Biorganic Med. Chem 5 (1997) 1543-1553.
17. [17] Beck J.R., Yahner J.A., J. Org. Chem. 41 (1976) 1733-1734.
18. [18] Clark J., Hitiris G., J. Chem. Soc. Perkin Trans. I (1984) 2005-2008.
19. [19] Peinador C., Moreira M.J., Quintela J.M., Tetrahedron 50 (1994) 6705-6714.
20. [20] Soto J.L., Seoane C., Rubio M.J., Botija J.M., Org. Prep. Proc. Int. 16 (1984) 11-24.
21. [21] Wagner G., Leistner S., Vieweg H., Krasselt U., Prantz J., Pharmazie 48 (1993) 514-518.
22. [22] Guerrera F., Salerno L., Sarva M.C., Siracusa M.A., Farmaco 48 (1993) 1725-1733.
23. [23] Peinador C., Veiga M.C., Quintela J.M., Heterocycles 38 (1994) 1299-1305.
24. [24] Scharemberg A.M., Kinet J.P., Chem. Immunol. 61 (1995) 72-87.
25. [25] Estevez M.D., Vieytes M.R., Louzao M.C., Alfonso A., Vilariño N., Botana L.M., Inflamm. Res. 46 (1997) 119-124.
26. [26] Estevez M.D., Vieytes M.R., Botana L.M., Agents Actions 42 (1994) 86-91.
27. [27] Estevez M.D., Vieytes M.R., Louzao M.C., Botana L.M., Biochem. Pharmacol. 47 (1994) 591-593.
28. [28] Shore P.A., Meth. Biochem. Anal. Suppl. (1971) 89-97.
29. [29] Bergeron R.J., Cavanaugh P.F., Kline S.J., Hughes R.G., Elliot G.T., Porter C.W., Biochem. Biophys. Res. Comm. 121 (1984) 848-854.